Amyotrophic lateral sclerosis (ALS) is a devastating disease that usually claims the lives of patients within a few years. But now a new drug developed by a team of Australian scientists has shown promise in a Phase 1 clinical trial, improving symptoms and slowing progression of the disease.
MS is a debilitating disease that damages myelin, the sheaths protecting neurons in the nervous system, leading to impaired motor skills and cognition. Now, researchers at Melbourne University have developed a synthetic peptide that helps regenerate myelin, potentially slowing progression of MS.
Scientists have vaccinated pregnant cows, in order to get them to produce HIV-inhibiting antibodies in their milk.